Many biomarkers, such as low-density lipoprotein receptor-related protein (LRP1), amyloid precursor protein (APP), amyloid-beta peptide 1–42 (Aβ 1–42), and tau-5, are affected by epigenetic risk factors and are highly associated with AD progression [5]. This evidence concerns the gene APP and Alzheimer disease.